IR415
(IR 415;IR-415);1-[3-(1-Imidazolyl)propyl]-3-(2,4-difluorophenyl)thiourea;IR415 >=98% (HPLC);Inhibitor,inhibit,cell,HepG2,HBX,IR 415,IR-415,replication,virus,IR415,Hepatitis B virus,HBV,VSR,hepatitis B;Thiourea, N-(2,4-difluorophenyl)-N'-[3-(1H-imidazol-1-yl)propyl]-;IR415, 10 mM in DMSO
IR415 is a potent anti-HBV agent that inhibits hepatitis B virus (HBV) replication by blocking the activity of HBx protein; it selectively interacts with HBx (Kd = 2 nM), reverses HBx-mediated suppression of Dicer endoribonuclease activity, and counteracts HBV-induced RNA interference (RNAi) suppression.